Tumour cell of origin in childhood malignant glioma impacts susceptibility to cancer therapy

Children that are diagnosed with the severe the brain tumour malignant glioma often have a very poor prognosis. Knowledge about how pediatric malignant glioma arises and develops is still limited. New findings from Uppsala University show that in mice glioma development and glioma cell properties are affected by both age and the cell type from which the tumour has arisen. The tumour cell of origin was also important for the susceptibility of the tumour cells towards cancer drugs.

Read more: http://www.news-medical.net/news/20161117/Tumour-cell-of-origin-in-childhood-malignant-glioma-impacts-susceptibilityc2a0to-cancer-therapy.aspx